These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 6115574)
1. Vasodilator and inotropic agents in treatment of chronic cardiac failure: clinical experience and response in exercise performance. Weber KT; Andrews V; Kinasewitz GT; Janicki JS; Fishman AP Am Heart J; 1981 Sep; 102(3 Pt 2):569-77. PubMed ID: 6115574 [TBL] [Abstract][Full Text] [Related]
2. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators. Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties. Bottorff MB; Rutledge DR; Pieper JA Pharmacotherapy; 1985; 5(5):227-37. PubMed ID: 3906583 [TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of amrinone-hydralazine combination on resting hemodynamics and exercise capacity in patients with severe congestive heart failure. Siegel LA; Keung E; Siskind SJ; Forman R; Feinberg H; Strom J; Efstathakis D; Sonnenblick EH; LeJemtel TH Circulation; 1981 Apr; 63(4):838-44. PubMed ID: 7471340 [No Abstract] [Full Text] [Related]
5. Problems in assessment of new pharmacologic agents for the heart failure patient. Rude RE; Grossman W; Colucci WS; Benotti JR; Carabello BA; Wynne J; Malacoff R; Braunwald E Am Heart J; 1981 Sep; 102(3 Pt 2):584-90. PubMed ID: 7270403 [TBL] [Abstract][Full Text] [Related]
6. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure. Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184 [TBL] [Abstract][Full Text] [Related]
7. Amrinone. A preliminary review of its pharmacological properties and therapeutic use. Ward A; Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1983 Dec; 26(6):468-502. PubMed ID: 6360634 [TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failure. Taylor CR; Baird JR; Blackburn KJ; Cambridge D; Constantine JW; Ghaly MS; Hayden ML; McIlhenny HM; Moore PF; Olukotun AY; Pullman LG; Salsburg DS; Saxton CA; Shevde S Am Heart J; 1981 Sep; 102(3 Pt 2):515-32. PubMed ID: 7023221 [TBL] [Abstract][Full Text] [Related]
9. Congestive heart failure. Ruggie N Med Clin North Am; 1986 Jul; 70(4):829-51. PubMed ID: 3012226 [TBL] [Abstract][Full Text] [Related]
10. Amrinone in the treatment of chronic cardiac failure. Likoff MJ; Weber KT; Andrews V; Janicki JS; Sutton MS; Wilson H; Rocci ML J Am Coll Cardiol; 1984 May; 3(5):1282-90. PubMed ID: 6707381 [TBL] [Abstract][Full Text] [Related]
11. Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study. DiBianco R; Shabetai R; Silverman BD; Leier CV; Benotti JR J Am Coll Cardiol; 1984 Nov; 4(5):855-66. PubMed ID: 6386932 [TBL] [Abstract][Full Text] [Related]
12. [Drug therapy of heart failure]. Follath F Ther Umsch; 1993 Jun; 50(6):425-33. PubMed ID: 8351674 [TBL] [Abstract][Full Text] [Related]
13. Amrinone--a new inotropic agent in chronic resistant congestive cardiac failure. Robinson PJ; Lvoff R; Chong B; Barrett PA Aust N Z J Med; 1981 Dec; 11(6):666-8. PubMed ID: 6949545 [TBL] [Abstract][Full Text] [Related]
14. New positive inotropic drugs for the treatment of congestive heart failure. Sonnenblick EH; Mancini DM; LeJemtel TH Am J Cardiol; 1985 Jan; 55(2):41A-44A. PubMed ID: 2981465 [TBL] [Abstract][Full Text] [Related]
15. Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial. Massie B; Bourassa M; DiBianco R; Hess M; Konstam M; Likoff M; Packer M Circulation; 1985 May; 71(5):963-71. PubMed ID: 3886191 [TBL] [Abstract][Full Text] [Related]
16. Combination of positive inotropic and vasodilating substances in congestive heart failure. Cantelli I; Bracchetti D Cardiovasc Drugs Ther; 1988 May; 2(1):83-91. PubMed ID: 3154699 [TBL] [Abstract][Full Text] [Related]
17. Review: therapeutic concepts of congestive heart failure. Haustein KO Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):273-81. PubMed ID: 1974888 [TBL] [Abstract][Full Text] [Related]
18. Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure. Aronow WS; Greenfield RS; Alimadadian H; Danahy DT Am J Cardiol; 1977 Nov; 40(5):789-93. PubMed ID: 335867 [TBL] [Abstract][Full Text] [Related]
20. Clinical effects and side effects of amrinone. A study of 24 patients with chronic congestive heart failure. Silverman BD; Merrill AJ; Gerber L Arch Intern Med; 1985 May; 145(5):825-9. PubMed ID: 3994460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]